Abelardo Aguilera

4.1k total citations · 1 hit paper
60 papers, 3.2k citations indexed

About

Abelardo Aguilera is a scholar working on Nephrology, Surgery and Physiology. According to data from OpenAlex, Abelardo Aguilera has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Nephrology, 17 papers in Surgery and 9 papers in Physiology. Recurrent topics in Abelardo Aguilera's work include Dialysis and Renal Disease Management (33 papers), Parathyroid Disorders and Treatments (11 papers) and Muscle and Compartmental Disorders (8 papers). Abelardo Aguilera is often cited by papers focused on Dialysis and Renal Disease Management (33 papers), Parathyroid Disorders and Treatments (11 papers) and Muscle and Compartmental Disorders (8 papers). Abelardo Aguilera collaborates with scholars based in Spain, Sweden and Mexico. Abelardo Aguilera's co-authors include Rafael Selgas, M. Auxiliadora Bajo, Manuel López‐Cabrera, Gloria del Peso, José Antonio Sánchez-Tomero, José A. Jiménez‐Heffernan, Luiz Stark Aroeira, Marta Ramírez‐Huesca, Francisco Sánchez‐Madrid and Marı́a Yáñez-Mó and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Abelardo Aguilera

60 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells

2003 640 citations Marı́a Yáñez-Mó, Enrique Lara‐Pezzi et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Abelardo Aguilera

Since Specialization

Citations

This map shows the geographic impact of Abelardo Aguilera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abelardo Aguilera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abelardo Aguilera more than expected).

Fields of papers citing papers by Abelardo Aguilera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abelardo Aguilera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abelardo Aguilera. The network helps show where Abelardo Aguilera may publish in the future.

Co-authorship network of co-authors of Abelardo Aguilera

This figure shows the co-authorship network connecting the top 25 collaborators of Abelardo Aguilera. A scholar is included among the top collaborators of Abelardo Aguilera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abelardo Aguilera. Abelardo Aguilera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition 2019 ·Frontiers in Pharmacology ·Lorena Ávila-Carrasco, Pedro Majano, José Antonio Sánchez-Tomero, Rafael Selgas, Manuel López‐Cabrera, Abelardo Aguilera, Guadalupe Tirma Gónzalez-Mateo	160
2	Enfermedad óseo mineral relacionada con la enfermedad renal crónica: Klotho y FGF23; implicaciones cardiovasculares 2016 ·Nefrología ·(unknown), Sánchez González, (unknown), Abelardo Aguilera, (unknown)	13
3	Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT 2015 ·BioMed Research International ·Guadalupe Tirma Gónzalez-Mateo, (unknown), Jesús Loureiro, Hugo Abensur, Pilar Sandoval, José Antonio Sánchez-Tomero, Gloria del Peso, José A. Jiménez‐Heffernan, (unknown), Rafael Selgas, Manuel López‐Cabrera, Abelardo Aguilera, (unknown)	23
4	PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage 2010 ·Laboratory Investigation ·Pilar Sandoval, Jesús Loureiro, Guadalupe Tirma Gónzalez-Mateo, Marı́a Luisa Lozano, (unknown), José Antonio Sánchez-Tomero, Lorea Mendoza, Beatriz Santamaría, Alberto Ortíz, Marta Ruiz‐Ortega, Rafael Selgas, Pilar Martı́n, Francisco Sánchez‐Madrid, Abelardo Aguilera, Manuel López‐Cabrera	54
5	Tissue distribution of hyalinazing vasculopathy lesions in peritoneal dialysis patients 2008 ·Pathology - Research and Practice ·José A. Jiménez‐Heffernan, Cristian Perna, M. Auxiliadora Bajo, María L. Picazo, Gloria del Peso, Luiz Stark Aroeira, Abelardo Aguilera, Eva Tejerina, Manuel López‐Cabrera, Rafael Selgas	6
6	Effects of Tamoxifen on Epithelial-to-Mesenchymal Transition, Fibrosis, and Angiogenesis of Mesothelial Cells 2007 ·Peritoneal Dialysis International ·Abelardo Aguilera, (unknown), (unknown), M. Auxiliadora Bajo, José A. Jiménez‐Heffernan, (unknown), Manuel López‐Cabrera, Rafael Selgas	2
7	Brain Activation in Uremic Anorexia 2007 ·Journal of Renal Nutrition ·Abelardo Aguilera, José Antonio Sánchez-Tomero, Rafael Selgas	14
8	Appetite Disorders in Uremia 2007 ·Journal of Renal Nutrition ·Juan Jesús Carrero, Abelardo Aguilera, Peter Stenvinkel, Fernando Gil, Rafael Selgas, Bengt Lindholm	86
9	Epithelial-to-mesenchymal transition of the mesothelial cell—its role in the response of the peritoneum to dialysis 2006 ·Nephrology Dialysis Transplantation ·Rafael Selgas, (unknown), José A. Jiménez‐Heffernan, José Antonio Sánchez-Tomero, Gloria del Peso, Abelardo Aguilera, Manuel López‐Cabrera	92
10	Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end‐stage renal disease 2005 ·Clinical Endocrinology ·Juan J. Díez, Pedro Iglesias, María José Fernández‐Reyes, Abelardo Aguilera, M. Auxiliadora Bajo, (unknown), Rosa Codoceo, Rafael Selgas	107
11	Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor 2005 ·American Journal of Kidney Diseases ·Luiz Stark Aroeira, Abelardo Aguilera, Rafael Selgas, Marta Ramírez‐Huesca, Marı́a Luisa Lozano, Antonio Cirugeda, M. Auxiliadora Bajo, Gloria del Peso, José Antonio Sánchez-Tomero, José A. Jiménez‐Heffernan, Manuel López‐Cabrera	165
12	Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis 2005 ·Clinical Endocrinology ·(unknown), Juan J. Díez, María José Fernández‐Reyes, Rosa Codoceo, (unknown), M. Auxiliadora Bajo, Abelardo Aguilera, Rafael Selgas	34
13	Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis 2004 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·José A. Jiménez‐Heffernan, Abelardo Aguilera, Luiz Stark Aroeira, Enrique Lara‐Pezzi, M. Auxiliadora Bajo, Gloria del Peso, (unknown), Carlos Gamallo, José Antonio Sánchez-Tomero, Vicente Álvarez, Manuel López‐Cabrera, Rafael Selgas	92
14	Growth hormone, IGF‐I and its binding proteins (IGFBP‐1 and ‐3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis 2004 ·Clinical Endocrinology ·Pedro Iglesias, Juan J. Díez, María José Fernández‐Reyes, (unknown), M. Auxiliadora Bajo, Abelardo Aguilera, Rafael Selgas	29
15	Eating Behavior Disorders in Uremia: A Question of Balance in Appetite Regulation 2004 ·Seminars in Dialysis ·Abelardo Aguilera, Rosa Codoceo, M. Auxiliadora Bajo, Pedro Iglesias, Juan J. Díez, Guillermina Barril, Secundino Cigarrán, Vicente Álvarez, (unknown), (unknown), (unknown), Rafael Selgas	49
16	Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells breakdown → 2003 ·New England Journal of Medicine ·Marı́a Yáñez-Mó, Enrique Lara‐Pezzi, Rafael Selgas, Marta Ramírez‐Huesca, Carmen Domı́nguez-Jiménez, José A. Jiménez‐Heffernan, Abelardo Aguilera, José Antonio Sánchez-Tomero, M. Auxiliadora Bajo, (unknown), M. Angeles Castro, Gloria del Peso, (unknown), Carlos Gamallo, Francisco Sánchez‐Madrid, Manuel López‐Cabrera	640
17	Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities 2003 ·American Journal of Kidney Diseases ·Abelardo Aguilera, M. Auxiliadora Bajo, (unknown), Antonio Olveira, (unknown), Rosa Codoceo, (unknown), Sonia P. Sanchez, (unknown), María José Castro, Rafael Selgas	36
18	Uremic Anorexia: A Consequence of Persistently High Brain Serotonin Levels? The Tryptophan/Serotonin Disorder Hypothesis 2000 ·Peritoneal Dialysis International ·Abelardo Aguilera, Rafael Selgas, Rosa Codoceo, (unknown)	30
19	Stability of the Peritoneal Membrane in Long-Term Peritoneal Dialysis Patients 1998 ·Advances in Renal Replacement Therapy ·Rafael Selgas, M. Auxiliadora Bajo, (unknown), Gloria del Peso, C. Méndez Díaz, Abelardo Aguilera, Covadonga Hevia	20
20	Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients 1997 ·American Journal of Kidney Diseases ·(unknown), Miguel A. Lasunción, Maite Rivera, Abelardo Aguilera, H. Ortega, A Tato, Roberto Marcén, J. Ortuño	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact